Frequency of glucocorticoid resistance and dependency in Crohn's disease
about
Vedolizumab for induction and maintenance of remission in Crohn’s diseaseMycophenolate mofetil for induction of remission in Crohn's diseaseCorticosteroids for maintenance of remission in Crohn's diseaseCurrent stage in inflammatory bowel disease: What is next?Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory careProfile of ustekinumab and its potential in patients with moderate-to-severe Crohn's disease.Glucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implicationsOptimization of the treatment with immunosuppressants and biologics in inflammatory bowel diseaseMicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseasesIndications and surgical options for small bowel, large bowel and perianal Crohn's diseaseNew steroids and new salicylates in inflammatory bowel disease: a critical appraisalPharmacogenetics in inflammatory bowel diseaseSevere and steroid-resistant Crohn's diseaseSwitch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's diseaseEfficacy of parenteral methotrexate in refractory Crohn's disease.Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance.New means to monitor the effect of glucocorticoid therapy in children.Anti-TNF antibody treatment of Crohn's disease.Review article: efficacy of infliximab in Crohn's disease--induction and maintenance of remission.Clinical epidemiology and phenotypic characteristics of Crohn's disease in the central region of Saudi Arabia.How to do without steroids in inflammatory bowel disease.Conventional therapy for Crohn's diseaseTherapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn's disease.Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease--do we have reliable markers?Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients.Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients.The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Recent advances in inflammatory bowel disease.Identification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation.Review article: the limitations of corticosteroid therapy in Crohn's disease.Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.Change in the treatment strategy for pediatric Crohn's diseaseCertolizumab pegol: an evidence-based review of its place in the treatment of Crohn's diseaseThe epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review.A critical assessment of new therapies in inflammatory bowel disease.Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresisInfliximab therapy in pediatric Crohn's disease: a review.Treatment of inflammatory bowel disease in childhood: best available evidence.Corticosteroid therapy in ulcerative colitis: Clinical response and predictors.Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease.
P2860
Q24187571-2C6F086A-A9DD-4711-A4C8-FA8790B2D3EAQ24234879-0B6D1900-3BBB-4478-B465-459B41FF8864Q24247756-D583A04B-F0EC-4CAE-A25C-41340504D083Q26777429-072C97ED-8CDF-41F3-9047-286DCC23B519Q26823569-37EB9576-E2B5-4A1A-A6C7-98BCE18866E9Q26825174-45D6C4AC-6693-4602-AC0C-E6323E128D0CQ26866110-F955BF96-7902-40B3-877B-9B300E35B889Q26866940-C1237BF2-84A7-4BF9-A58A-B6ACE30687A4Q27011618-C3B4628C-454D-4191-81B1-8CE5D25847EDQ28079926-26674724-D92F-41CF-A59A-4B0A7913B411Q28192793-3BC234FC-CBAB-49D4-A201-6F716A4D5890Q28246002-D6D73192-CCD9-40E0-8E75-FBF03BB1D4F6Q28266806-67D4581C-FBD6-4C32-A592-A393904D7F40Q28345937-F6232E19-E167-4F3B-B0AC-10C717B5668FQ31795133-25B3295D-BBFB-4798-9F32-178EC0CD7917Q32026645-C1EFE348-353B-4BBA-B111-F9DD98CC0DE2Q33716295-2219DC3C-283D-43CF-B334-A7DF2265D27AQ33782391-6607F1AF-82B6-4396-87B9-F3FAF70E4E33Q33793926-292338AB-757F-4268-A745-2D1CA3E167A4Q33796025-1EAD0FD7-E608-4C9F-ABF0-2F88971E2243Q33853564-B49AC26B-75BF-4900-A7DB-8476A1798BC6Q33866982-EC374ECD-02BC-43F0-B4E1-0FE556B2F923Q33926396-80D91514-A5A5-4A8C-9058-98C9059DD4B7Q33930756-62645762-B81B-49E7-B757-03C2B54A3F43Q33983369-E532FE3B-02FA-40D8-A745-C153A5FB9564Q34073595-576848DD-7F12-4D12-81C4-9AD097B1A039Q34147687-4B8D9A47-3054-46C4-B637-90BEEDD3A870Q34188405-C52D0CDA-CCE9-4ACF-A1FB-72EDA6888EE6Q34321183-57B7BEFF-1470-4FB2-892D-1B3225D9C631Q34374135-9243543D-5ABB-4E63-8AAA-975B3BCEDA03Q34409966-B7A680F9-BB15-4C1C-9B8C-181325DB2C89Q34420755-EAEE8852-7B1C-4082-ADB4-1E6C4EDDB71CQ34449843-A09FD01B-C0C8-4E6B-A8A1-45D0FE6C97F7Q34521232-245B4227-3FA3-4F4C-BAD5-5820D724F0A3Q34631399-4819C5AC-BCD5-40DF-98BA-93664C7F083EQ34831143-1D4027FC-9B09-4222-8BEB-CC4B20361EA5Q35026358-514D01EB-B240-47C2-B188-3C271EBCF794Q35091746-F130D342-CDEB-4761-B1D0-78C8B82348C4Q35169366-6118C022-3D3F-4485-B2B1-F0D12304289FQ35595464-FB23B1EA-FD83-46ED-9947-6716DDD8DA5F
P2860
Frequency of glucocorticoid resistance and dependency in Crohn's disease
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@ast
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@en
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@nl
type
label
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@ast
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@en
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@nl
prefLabel
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@ast
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@en
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@nl
P2093
P2860
P356
P1433
P1476
Frequency of glucocorticoid resistance and dependency in Crohn's disease
@en
P2093
P2860
P304
P356
10.1136/GUT.35.3.360
P407
P577
1994-03-01T00:00:00Z